Pulmonary tuberculosis: Diagnosis and treatment

British Medical Journal

Volumn 332, Issue 7551, 2006, Pages 1194-1197

  Campbell, Ian A ^a   Bah Sow, Oumou ^b  

^a LLANDOUGH HOSPITAL   (United Kingdom)

^b Guinée Centre de Recherche et de Formation en Infectiologie de Guinée Guinean infectiology research and training center   (Guinea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BCG VACCINE; ETHAMBUTOL; ISONIAZID; ISONIAZID PLUS RIFAMPICIN; PYRAZINAMIDE; PYRIDOXINE; RIFAMPICIN; RIFATER; THIOACETAZONE; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CHEMOTHERAPY; CLINICAL FEATURE; CONTACT EXAMINATION; CROSS INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MULTIDRUG RESISTANCE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SPUTUM CULTURE; SYMPTOM; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; BUDGET; DRUG COST; ECONOMICS; LUNG TUBERCULOSIS; MICROBIOLOGY; SPUTUM;

ANTITUBERCULAR AGENTS; BCG VACCINE; BUDGETS; CROSS INFECTION; DRUG COSTS; HUMANS; RADIOGRAPHY, THORACIC; SPUTUM; TUBERCULIN TEST; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 33646950447     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.332.7551.1194     Document Type: Review

References (24)

1. Tackling poverty in tuberculosis control. Lancet 2005;366:2063.
2. Dye C. Global epidemiology of tuberculosis. Lancet 2006;367:938-40.
3. Dormandy T. The white death. London: Hambledon Press, 1999.
4. Coker R, McKee M, Atun R, Dimitrova B, Dodonova E, Kuznetsov S, et al. Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ 2006;332:85-7.
5. National Institute for Health and Clinical Excellence. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: NICE, 2006. Available at: www.nice.org.uk/page. aspx?o = CG033.
6. Snider DE, Roper WL. The new tuberculosis. N Engl J Med 1992;326:703-5.
7. Cantwell MF, Snider DE Jr, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA 1994;272:535-9.
8. Raviglione MC, Snider DE, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a world-wide epidemic. JAMA 1995;273:220-6.
9. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003;163:1009-12.
10. Crampin AC, Floyd S, Mwaungulu E, Black G, Ndhlovu R, Mwaiyeghele E, et al. Comparison of two versus three smears in identifying culture-positive tuberculosis patients in a rural African setting with high HIV prevalence. Int J Tuberc Lung Dis 2001;5:994-9.
11. Schaaf HS, Beyers N, Gie RB, Schaaf HS, Beyers N, Gie RP, et al. Respiratory tuberculosis in children: the diagnostic value of clinical features and special investigations. Pediatr Infect Dis J 1995;14:189-94.
12. Crofton J, Horne N, Miller F. Clinical tuberculosis. 2nd ed. London: Macmillan, 1999.
13. Enarson PM, Enarson DA, Gie R. Management of tuberculosis in children in low-income countries. Int J Tuberc Lung Dis 2005;9:1299-304.
14. Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998;53:536-48.
15. Enarson D, Reider H, Arnadottir T, Trebucq A. Management of tuberculosis, a guide for low income countries. Paris: International Union Against Tuberculosis and Lung Diseases, 2000.
16. World Health Organization Stop TB Department Treatment of tuberculosis: guidelines for national programmes. 3rd ed. Geneva: WHO, 2003.
17. Joint Tuberculosis Committee of One British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Thorax 2000;55:887-901.
18. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 2003;(1):CD003343.
19. Harries AD, Hargreaves NJ, Salaniponi FM. Design of regimens for treating tuberculosis in patients with HIV infection, with particular reference to sub-Saharan Africa. Int J Tuberc Lung Dis 2001;5:1109-15.
20. Pozniak AL, Miller RF, Lipman MCI, Freedman AR, Ormerod LP, Johnson MA, et al. British HIV Association treatment guidelines for TB/HIV infection: February 2005. www.bhiva.org (accessed Dec 2005).
21. Anderson P, Doherty TM. The success and failure of BCG: implications for a novel tuberculosis vaccine. Nat Rev Microbiol 2005;3:656-62.
22. Fox W, Andrews RH, Ramakrishnan CV. A concurrent comparison of home and sanatorium treatment of pulmonary tuberculosis in South India. Bull World Health Organ 1959;21:51-144.
23. Rouillon A, Predizet S, Parrot R. Transmission of tubercle bacilli: the effects of chemotherapy. Tubercle 1976;57:275-99.
24. Stop TB Partnership and World Health Organization. Global plan to stop TB 2006-2015. Geneva: WHO, 2006. (WHO/HTM/STB 2006.35.) (Accepted 3 April 2006)